IGMSX
Price
$9.49
Change
+$0.02 (+0.21%)
Updated
Sep 20 closing price
NPFFX
Price
$64.39
Change
-$0.39 (-0.60%)
Updated
Sep 20 closing price
Ad is loading...

IGMSX vs NPFFX

Header iconIGMSX vs NPFFX Comparison
Open Charts IGMSX vs NPFFXBanner chart's image
Voya Global Insights Portfolio S
Price$9.49
Change+$0.02 (+0.21%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective F1
Price$64.39
Change-$0.39 (-0.60%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IGMSX vs NPFFX Comparison Chart
Loading...
VS
IGMSX vs. NPFFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IGMSX is a StrongBuy and NPFFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
NPFFX has more cash in the bank: 145B vs. IGMSX (1.13B). NPFFX pays higher dividends than IGMSX: NPFFX (0.79) vs IGMSX (0.00). IGMSX was incepted earlier than NPFFX: IGMSX (22 years) vs NPFFX (24 years). IGMSX is a more actively managed with annual turnover of: 107.00 vs. NPFFX (17.00). IGMSX has a lower initial minimum investment than NPFFX: IGMSX (0) vs NPFFX (250). NPFFX annual gain was more profitable for investors over the last year : 22.78 vs. IGMSX (-36.01). NPFFX return over 5 years is better than : 45.68 vs. IGMSX (-42.90).
IGMSXNPFFXIGMSX / NPFFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years24 years-
Gain YTD-43.22516.081-269%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.13B145B1%
Annual Yield % from dividends0.000.79-
Returns for 1 year-36.0122.78-158%
Returns for 3 years-62.26-4.181,488%
Returns for 5 years-42.9045.68-94%
Returns for 10 years-45.7771.08-64%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KSS18.680.06
+0.32%
Kohls Corp
TIMB16.95-0.05
-0.29%
TIM SA
YORW37.90-1.09
-2.80%
York Water Company
INM0.26-0.01
-3.00%
InMed Pharmaceuticals
HOWL2.19-0.21
-8.75%
Werewolf Therapeutics